The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 339:921-922 September 24, 1998 Number 13
NextNext

Multidrug-Resistant Salmonella enterica Serotype Typhimurium Infections

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Glynn, M. K.
-PubMed Citation
To the Editor: Glynn et al. (May 7 issue)1 have shown that infections due to a strain of Salmonella enterica serotype typhimurium, known as definitive type 104 (DT104), that is resistant to ampicillin, chloramphenicol, streptomycin, sulfonamides, and tetracycline have increased in the past 15 years in the United States. The authors mention that "no one method . . . is capable of identifying five-drug–resistant typhimurium DT104" and suggest the use of screening "for resistance to chloramphenicol . . . for identifying isolates with the five-drug pattern of resistance."

Despite the robust epidemiologic evidence linking the phage type DT104 to the . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.